Biotech Values

[mcbio]

Re: Arzerra vs. RIGL's R788 in RA

I don't think you can make this case because the placebo-adjusted RR is about the same

There's always a caveat in comparing data across separate trials so I can acknowledge that. But, the placebo-adjusted RR appears to be 31% for R788 versus 23% for Arzerra. That appears to be a meaningful difference to me.